Related Experiment Video
Updated: Jan 30, 2026

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis
Published on: June 9, 2018
Transthyretin Aggregation Pathway toward the Formation of Distinct Cytotoxic Oligomers
Anvesh K R Dasari1, Robert M Hughes1, Sungsool Wi2
1Department of Chemistry, East Carolina University, Greenville, NC, 27858, USA.
Abstract:
Characterization of small oligomers formed at an early stage of amyloid formation is critical to understanding molecular mechanism of pathogenic aggregation process. Here we identified and characterized cytotoxic oligomeric intermediates populated during transthyretin (TTR) aggregation process. Under the amyloid-forming conditions, TTR initially forms a dimer through interactions between outer strands. The dimers are then associated to form a hexamer with a spherical shape, which serves as a building block to self-assemble into cytotoxic oligomers. Notably, wild-type (WT) TTR tends to form linear oligomers, while a TTR variant (G53A) prefers forming annular oligomers with pore-like structures. Structural analyses of the amyloidogenic intermediates using circular dichroism (CD) and solid-state NMR reveal that the dimer and oligomers have a significant degree of native-like β-sheet structures (35-38%), but with more disordered regions (~60%) than those of native TTR. The TTR variant oligomers are also less structured than WT oligomers. The partially folded nature of the oligomeric intermediates might be a common structural property of cytotoxic oligomers. The higher flexibility of the dimer and oligomers may also compensate for the entropic loss due to the oligomerization of the monomers.
Insights
Researchers identified early-stage transthyretin (TTR) oligomers, revealing their partially folded structures and role in pathogenic aggregation. Understanding these cytotoxic intermediates is key to unraveling amyloid formation mechanisms.
Area of Science:
- Biochemistry
- Molecular Biology
- Structural Biology
Background:
- Amyloid formation is linked to pathogenic aggregation processes.
- Early-stage oligomers are critical for understanding these mechanisms.
- Transthyretin (TTR) aggregation is implicated in various diseases.
Purpose of the Study:
- To identify and characterize cytotoxic oligomeric intermediates during TTR aggregation.
- To elucidate the structural properties of these early-stage TTR oligomers.
- To compare the aggregation pathways of wild-type (WT) TTR and a G53A variant.
Main Methods:
- Amyloid formation under specific conditions.
- Structural analysis using circular dichroism (CD).
- Solid-state Nuclear Magnetic Resonance (NMR) spectroscopy.
Main Results:
- TTR initially forms dimers, which assemble into hexamers, serving as building blocks for cytotoxic oligomers.
- Wild-type TTR forms linear oligomers, while the G53A variant forms annular, pore-like oligomers.
- Oligomers exhibit significant native-like beta-sheet structures (35-38%) but are more disordered (~60%) than native TTR; variant oligomers are less structured.
Conclusions:
- Cytotoxic oligomers share partially folded structures, suggesting a common property.
- The flexibility of TTR oligomers may offset entropic losses during aggregation.
- Characterizing these intermediates provides insights into TTR-mediated amyloidosis.
Related Concept Videos
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...
Aggregates Classification
Petrographic classification groups aggregates based on common mineralogical characteristics. Some of the common mineral groups found in aggregates are...
Formation of Species
Solution Formation
This selective...
Other Glycolytic Pathways
Auditory Pathway
When viewed cross-sectionally, the cochlea reveals the scala vestibuli and scala tympani flanking...

